Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Diagnostic or test agent produces in vivo fluorescence
Reexamination Certificate
2001-10-17
2004-07-13
Jones, Dameron L. (Department: 1616)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Diagnostic or test agent produces in vivo fluorescence
C424S001110, C424S001650, C424S009100, C548S400000, C548S416000, C548S427000
Reexamination Certificate
active
06761878
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to novel dye-bioconjugates for use in diagnosis and therapy, particularly novel compositions of cyanine dye bioconjugates of bioactive molecules.
BACKGROUND OF THE INVENTION
Cancer will continue to be a primary cause of death for the foreseeable future, but early detection of tumors would improve patient prognosis (R. T. Greenlee et al.,
Cancer statistics,
2000, CA Cancer
J. Clin.,
2000, 50, pp. 7-33). Despite significant advances in current methods for the diagnosis of cancer, physicians still rely on the presence of a palpable tumor mass. At this, however, the many benefits of early medical intervention may have been already compromised.
Photodiagnosis and/or phototherapy has a great potential to improve management of cancer patient (D. A. Benaron and D. K. Stevenson,
Optical time
-
of
-
flight and absorbance imaging of biologic media
, Science, 1993, 259, pp. 1463-1466; R. F. Potter (Series Editor),
Medical optical tomography: functional imaging and monitoring
, SPIE Optical Engineering Press, Bellingham, 1993; G. J. Tearney et al.,
In vivo endoscopic optical biopsy with optical coherence tomography
, Science, 1997, 276, pp. 2037-2039; B. J. Tromberg et al.,
Non
-
invasive measurements of breast tissue optical properties using frequency—domain photon migration, Phil. Trans. Royal Society London B,
1997, 352, pp. 661-668; S. Fantini et al.,
Assessment of the size, position, and optical properties of breast tumors in vivo by non
-
invasive optical methods, Appl. Opt.,
1998, 37, pp. 1982-1989; A. Pelegrin et al.,
Photoimmunodiagnosis with antibody
-
fluorescein coniugates: in vitro and in vivo preclinical studies, J. Cell Pharmacol.,
1992, 3, pp. 141-145). These procedures use visible or near infrared light to induce the desired effect. Both optical detection and phototherapy have been demonstrated to be safe and effective in clinical settings and biomedical research (B. C. Wilson,
Optical properties of tissues, Encyclopedia of Human Biology,
1991, 5, 587-597; Y-L. He et al.,
Measurement of blood volume using indocyanine green measured with pulse
-
spectrometry: Its reproducibility and reliability, Critical Care Medicine,
1998, 26, pp. 1446-1451; J. Caesar et al.,
The use of Indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function, Clin. Sci.,
1961, 21, pp. 43-57; R. B. Mujumdar et al.,
Cyanine dye labeling reagents: Sulfoindocyanine succinimidyl esters, Bioconjugate Chemistry,
1993, 4, pp. 105-111; U.S. Pat. No. 5,453,505; Eric Hohenschuh, et al.,
Light imaging contrast agents
, WO 98/48846; Jonathan Turner, et al.,
Optical diagnostic agents for the diagnosis of neurodegenerative diseases by means of near infrared radiation,
WO 98/22146; Kai Licha, et al.,
In
-
vivo diagnostic process by near infrared radiation
, WO 96/17628; Robert A. Snow, et al.,
Compounds
, WO 98/48838].
Dyes are important to enhance signal detection and/or photosensitizing of tissues in optical imaging and phototherapy. Previous studies have shown that certain dyes can localize in tumors and serve as a powerful probe for the detection and treatment of small cancers (D. A. Bellnier et al.,
Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer
2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-
a, J. Photochem. Photobiol.,
1993, 20, pp. 55-61; G. A. Wagnieres et al.,
In vivo fluorescence spectroscopy and imaging for oncological applications, Photochem. Photobiol.,
1998, 68, pp. 603-632; J. S. Reynolds et al.,
Imaging of spontaneous canine mammary tumors using fluorescent contrast agents, Photochem. Photobiol.,
1999, 70, pp. 87-94). However, these dyes do not localize preferentially in malignant tissues.
Efforts have been made to improve the specificity of dyes to malignant tissues by conjugating dyes to large biomolecules (A. Pelegrin, et al.,
Photoimmunodiagnosis with antibody
-
fluorescein conjugates: in vitro and in vivo preclinical studies, J. Cell Pharmacol.,
1992, 3, pp. 141-145; B. Ballou et al.,
Tumor labeling in vivo using cyanine
-
coniugated monoclonal antibodies, Cancer Immunol. Immunother.,
1995, 41, pp. 257-263; R. Weissleder et al.,
In vivo imaging of tumors with protease
-
activated near
-
infrared fluorescent probes, Nature Biotech.,
1999, 17, pp. 375-378; K. Licha et al.,
New contrast agents for optical imaging: Acid
-
cleavable conjugates of cyanine dyes with biomolecules, Proc. SPIE,
1999, 3600, pp. 29-35). Developing a dye that can combine the roles of tumor-seeking, diagnostic, and therapeutic functions has been very difficult for several reasons. The dyes currently in use localize in tumors by a non-specific mechanism that usually relies on the lipophilicity of the dye to penetrate the lipid membrane of the cell. These lipophilic dyes require several hours or days to clear from normal tissues, and low tumor-to-normal tissue ratios are usually encountered. Furthermore, combining photodynamic properties with fluorescence emission needed for the imaging of deep tissues requires a molecule that must compromise either the photosensitive effect of the dye or the fluorescence quantum yield. Photosensitivity of phototherapy agents relies on the transfer of energy from the excited state of the agent to surrounding molecules or tissues, while fluorescence emission demands that the excitation energy be emitted in the form of light (T. J. Dougherty et al.,
Photoradiation therapy II: Cure of animal tumors with hematoporphyrin and light
, Journal of National Cancer Institute, 1978, 55, pp. 115-121). Therefore, compounds and compositions that have optimal tumor-targeting ability to provide a highly efficient photosensitive agent for treatment of tumors are needed. Such agents would exhibit enhanced specificity for tumors and would also have excellent photophysical properties for optical detection.
Each of the references previously disclosed is expressly incorporated by reference herein in its entirety.
SUMMARY OF THE INVENTION
The invention is directed to a composition for a carbocyanine dye bioconjugate. The bioconjugate consists of three components: 1) a tumor specific agent, 2) a photosensitizer (phototherapy) agent, and 3) a photodiagnostic agent. The inventive bioconjugates use the multiple attachment points of carbocyanine dye structures to incorporate one or more receptor targeting and/or photosensitive groups in the same molecule. The composition may be used in various biomedical applications.
The invention is also directed to a method for performing a diagnostic and therapeutic procedure by administering an effective amount of the composition of the cyanine dye bioconjugate to an individual. The method may be used in various biomedical applications, such as imaging tumors, targeting tumors with anti-cancer drugs, and performing laser guided surgery.
REFERENCES:
patent: 5453505 (1995-09-01), Lee et al.
patent: 6190641 (2001-02-01), Achilefu et al.
patent: WO 96/17628 (1996-06-01), None
patent: WO 98/22146 (1998-05-01), None
patent: WO 98/48838 (1998-11-01), None
patent: WO 98/48846 (1998-11-01), None
Woolam et al.,Cancer Statistics, 2000: A Benchmark for the New Century, 2000, CA-A Cancer Journal For Clinicians, 50 (1), pp. 6-33.
Caesar et al.,The Use of Indocyanine Green in the Measurement of Hepatic Blood Flow and as a Test of Hepatic Function, 1961, Clinical Science, 21, pp. 43-57.
Mujumdar et al.,Cyanine Dye Labeling Reagents: Sulfoindocyanine Succinimidyl Esters, 1993, Bioconjugate Chemistry, 4 (2), pp. 105-111.
Bellnier et al.,Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a, 1993, Journal of Photochemistry and Photobiology B: Biology, 20, pp. 55-61.
Wagnieres et al.,In Vivo Fluorescence Spectroscopy and Imaging for Oncological Applications, 1998, Photochemistry and Photobiology, 68 (5), pp. 603-632.
Reynolds et al.,Imaging of Spontaneous Canine Mammary Tumors Using Fluorescent Contrast Agents, 1999, Photochemistry and Photobiology, 70 (1)
Achilefu Samuel
Bugaj Joseph E.
Dorshow Richard B.
Rajagopalan Raghavan
Jones Dameron L.
Mallinckrodt Inc.
LandOfFree
Pathological tissue detection and treatment employing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pathological tissue detection and treatment employing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pathological tissue detection and treatment employing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3215012